Maiden results and new deals for BioProgress
Capsule technology company BioProgress has reported its first set of interim results since becoming an AIM-listed company, as well as a distribution deal with Hoefliger.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs